Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans.

TitleAssociation of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans.
Publication TypeJournal Article
Year of Publication2009
AuthorsRasouli N, Yao-Borengasser A, Varma V, Spencer HJ, McGehee RE, Peterson CA, Mehta JL, Kern PA
JournalArterioscler Thromb Vasc Biol
Volume29
Issue9
Pagination1328-35
Date Published2009 Sep
ISSN1524-4636
KeywordsAdipocytes, Adiponectin, Adult, Aged, CD36 Antigens, Cell Line, Coculture Techniques, Down-Regulation, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Macrophages, Male, Metformin, Middle Aged, Obesity, Pioglitazone, Receptors, Scavenger, RNA, Messenger, Scavenger Receptors, Class A, Scavenger Receptors, Class E, Subcutaneous Fat, Thiazolidinediones, Treatment Outcome, Young Adult
Abstract

OBJECTIVE: Scavenger receptors play crucial roles in the pathogenesis of atherosclerosis, but their role in insulin resistance has not been explored. We hypothesized that scavenger receptors are present in human adipose tissue resident macrophages, and their gene expression is regulated by adiponectin and thaizolidinediones.

METHODS AND RESULTS: The gene expression of scavenger receptors including scavenger receptor-A (SRA), CD36, and lectin-like oxidized LDL receptor-1 (LOX-1) were studied in subcutaneous adipose tissue of nondiabetic subjects and in vitro. Adipose tissue SRA expression was independently associated with insulin resistance. Pioglitazone downregulated SRA gene expression in adipose tissue of subjects with impaired glucose tolerance and decreased LOX-1 mRNA in vitro. Macrophage LOX-1 expression was decreased when macrophages were cocultured with adipocytes or when exposed to adipocyte conditioned medium. Adding adiponectin neutralizing antibody resulted in a 2-fold increase in LOX-1 gene expression demonstrating that adiponectin regulates LOX-1 expression.

CONCLUSIONS: Adipose tissue scavenger receptors are strongly associated with insulin resistance. Pioglitazone and adiponectin regulate gene expression of SRA and LOX-1, and this may have clinical implications in arresting the untoward sequalae of insulin resistance and diabetes, including accelerated atherosclerosis.

DOI10.1161/ATVBAHA.109.186957
Alternate JournalArterioscler. Thromb. Vasc. Biol.
PubMed ID19667111
PubMed Central IDPMC2755066
Grant ListR01 DK039176 / DK / NIDDK NIH HHS / United States
R37 DK039176 / DK / NIDDK NIH HHS / United States
R01 DK071349 / DK / NIDDK NIH HHS / United States
DK 71349 / DK / NIDDK NIH HHS / United States
DK 39176 / DK / NIDDK NIH HHS / United States
DK 71277 / DK / NIDDK NIH HHS / United States
R37 DK039176-21 / DK / NIDDK NIH HHS / United States
R01 DK071277 / DK / NIDDK NIH HHS / United States
R01 DK071277-04 / DK / NIDDK NIH HHS / United States
R01 DK071349-04 / DK / NIDDK NIH HHS / United States
UL1 TR001998 / TR / NCATS NIH HHS / United States
M01 RR014288 / RR / NCRR NIH HHS / United States
M01RR14288 / RR / NCRR NIH HHS / United States
P20 RR021954 / RR / NCRR NIH HHS / United States
P20 RR021954-02 / RR / NCRR NIH HHS / United States